申请人:Pfizer Inc.
公开号:US08779148B2
公开(公告)日:2014-07-15
The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors and, more specifically, their use to treat bacterial infections.
本发明涉及一种新的羟
肟酸衍
生物类,其作为LpxC
抑制剂的用途,更具体地,其用于治疗细菌感染。